• Oversee technical operations to develop novel true minimally invasive drug delivery and device solutions for unmet needs in urology• Lead and building team of R&D, Engineering, Manufacturing, Quality/CMC, Nonclinical, Clinical, Regulatory Affairs, and IT• Member of Board of Directors and participate in company strategy and fundraising

• Lead company R&D and interim Clinical organization of up to thirty employees across multiple sites, managed up to ~$16M annual budget• Company technical expert for local drug delivery for ENT from startup pre-IPO to greater than $100M revenue and $1.1B acquisition by MDT• Business development, due diligence, acquisition, and integration of Fiagon, acquisition by MDT• Presentations to board of directors, CEO, executive team, regulatory bodies (US, EU), due diligence• Portfolio strategic planning and clinical needs identification, KOL engagement, advisory board • Lead and execute pipeline and development programs from concept to market for drugs, combination products and medical devices • Submucosal corticosteroid eluting implant concept, drug formulation, CMC, preclinical and process development, clinical and regulatory strategy, business case • Lead VENSURE sinus dilation balloon product development including launch of improved balloon and inflation pump, 510k clearance and launch readiness of balloon lightguide design and improved packaging (divested as part of MDT acquisition)• PROPEL product family indication expansions, EU MDR, next generation implant and delivery device improvements

• Company’s expert on local drug delivery technology for ENT• Director of pipeline and development programs, technical teams• R&D pipeline porfolio strategy and member of business development team• Director of ASCEND drug coated dilation device program to clinical stage • Technical Leader for SINUVA NDA and PROPEL Contour PMA-S drug device combination products• Problem solver, commercial support of OOS, NCMR, CAPA, business initiatives, FDA/EU change submissions• Vendor, CRO, CMO selection and management• IP strategy and patent committee member

• Abbott Vascular 2013 Innovator of the Year• Concept and product development, direct reports/teams, budgets, timelines, funding• Manager for Renal Denervation RF Catheter program out of Corporate Incubator • Manager for Biologics Local Delivery Hydrogel program out of Corporate Incubator in collaboration with AbbVie Humira Team• Technical Leader for ESPRIT superficial femoral artery BVS program to Clinical Trial• Project Leader for peripheral vascular Drug Coated Balloon development program • IP strategy and patent committee member

Performed clinical technical support and emergency transport of ventricular assist devices/patients

Conducted advanced polyurethanes chemistry, molding, extrusion and testing for business groups